Skip to main content
. 2019 Aug 27;55(1):126–136. doi: 10.1038/s41409-019-0624-z

Fig. 1.

Fig. 1

Cumulative incidences of mortality after HSCT over four post-transplant phases and from cohort 1 to cohort 2. The stacked curves for the four post-transplant phases for the two cohorts combined in landmark analysis are presented: a 30-day mortality; b 100-day mortality (for patients alive at day 30); c 1-year mortality (for patients alive at day 100); d 5-year mortality (for patients alive at 1 year)